Once-a-month estrogen/progestogen injectables.
Entre Nous Cph Den
; (19): 15, 1991 Dec.
Article
em En
| MEDLINE
| ID: mdl-12222332
Palavras-chave
Amenorrhea; Asia; Biology; Bleeding; Blood Coagulation Effects; Carbohydrate Metabolic Effects; China; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin; Contraceptive Agents--side effects; Contraceptive Methods; Contraceptive Usage; Depo-provera--side effects; Developing Countries; Diseases; Eastern Asia; Endocrine System; Endometrium; Estradiol Enanthate; Family Planning; Fibrinolysis; Genitalia; Genitalia, Female; Glucose Metabolism Effects; Hematological Effects; Hemic System; Hormones; Injectables; International Agencies; Lipid Metabolic Effects; Lipids; Medroxyprogesterone Acetate--side effects; Megestrol Acetate; Menstruation Disorders; Metabolic Effects; Method Acceptability; Norethindrone Enanthate--side effects; Norethindrone--side effects; Organizations; Ovulation; Physiology; Progestational Hormones; Progesterone; Reproduction; Research Methodology; Signs And Symptoms; Un; Urogenital System; Uterus; Who
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Ovulação
/
Progesterona
/
Pesquisa
/
Organização Mundial da Saúde
/
Aceitação pelo Paciente de Cuidados de Saúde
/
Acetato de Medroxiprogesterona
/
Anticoncepcionais Orais Hormonais
/
Acetato de Megestrol
/
Países em Desenvolvimento
/
Endométrio
País como assunto:
Asia
Idioma:
En
Ano de publicação:
1991
Tipo de documento:
Article